Historical record - last NADAC effective date: 1/10/2019
Product Information
ZYTIGA 250 MG TABLET is a brand product labeled by Janssen Biotech, Inc., priced at $87.6254 per EA under NDC 57894015012. Its NADAC has been published 321 times since Nov 28, 2013.
FDA first approved this application on Apr 28, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the abiraterone acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 mg/1
Manufacturer
Janssen Biotech, Inc.NDC
57894015012
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
1/10/2019
Active Ingredients
ABIRATERONE ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA202379FDA Approved
4/28/2011
TE Code
AB
On Market Since
4/28/2011
Pharmacological Classes
Price Statistics
The NADAC for ZYTIGA 250 MG TABLET has been published 321 times since Nov 28, 2013, and over the history we have for it it has risen 59.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $87.6254 per EA |
|---|---|
| All-time high | $87.6254 (Jan 15, 2020) |
| All-time low | $54.2582 (Feb 18, 2015) |
| Median price | $69.4437 |
| Average price | $70.5085 |
| Largest weekly change | +9.4% (Aug 24, 2016) |
| Weeks tracked | 321 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+59.3%
Last surveyed Jan 15, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Janssen Biotech, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
abiraterone acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cytochrome P450 17A1 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZYTIGA 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZYTIGA 250 MG TABLET, manufactured by Janssen Biotech, Inc., is $87.6254 per EA (NDC 57894015012), effective Jan 15, 2020.
How has the price of ZYTIGA 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZYTIGA 250 MG TABLET has risen 59.3%. It has been tracked across 321 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ZYTIGA 250 MG TABLET?
Since Nov 28, 2013, the NADAC for ZYTIGA 250 MG TABLET has ranged from a low of $54.2582 (Feb 18, 2015) to a high of $87.6254 (Jan 15, 2020), with a median of $69.4437 per EA.
Are there cheaper alternatives to ZYTIGA 250 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ABIRATERONE ACETATE 250 MG TAB, is $0.7741 per EA — about 99% below ZYTIGA 250 MG TABLET.
Who manufactures ZYTIGA 250 MG TABLET?
ZYTIGA 250 MG TABLET (NDC 57894015012) is labeled by Janssen Biotech, Inc., and CMS classifies it as a brand product.